Skip to content
    BRO
    Earnings call· Mar 2026(Q1 FY26)

    BROWN & BROWN Q1 FY26 earnings call BRO

    Apr 28, 2026 Source

    Executive summary

    Brown & Brown Q1 FY26 — Solid Growth and Margin Expansion Amidst Market Headwinds

    Brown & Brown delivered solid Q1 FY26 results, driven by strong contingent commissions and disciplined expense management, despite flat organic growth ex-contingents. The company is navigating market headwinds, particularly in CAT property rates and a pharmacy consulting business model change, while actively integrating Accession and leveraging AI for future growth and efficiency. Management remains focused on deleveraging, strategic M&A, and capital returns.

    Highlights

    5
    • Total revenues grew 35.4% to $1.9 billion in Q1 FY26.

    • Adjusted EBITDAC margin increased 40 basis points to 38.5%.

    • Adjusted diluted EPS grew nearly 8% to $1.39.

    • Cash flow from operations increased approximately $50 million or 23% to over $260 million.

    • Contingent commissions grew by an impressive $54 million, with $22 million from Accession.

    Concerns

    5
    • Organic revenue growth (ex-contingents) was flat with the prior year, impacted by a negative 100 basis points from prior year flood claims processing revenue.

    • Retail segment organic growth (ex-contingents) was 1%, with a pharmacy consulting business revenue model change expected to negatively impact growth by 50-100 basis points over the next couple of quarters.

    • Specialty Distribution organic growth (ex-contingents) decreased 2%, negatively impacted by 300 basis points from prior year flood claims processing revenue.

    • E&S CAT property rates declined significantly, down 15% to 35%, with further declines later in the quarter.

    • Litigation with a start-up broker has resulted in $31 million of annualized lost revenue, with a $10 million impact in Q1.

    Guidance & targets

    7
    CategoryTargetConfidence
    Retail Organic Growth
    modest organic growth improvement each quarter this year as compared to the first quarter
    medium materiality
    Medium
    Specialty Distribution Organic Growth (excl. contingents)
    relatively flat
    medium materiality
    Medium
    Specialty Distribution Organic Growth (excl. contingents)
    improving growth
    medium materiality
    Medium
    Accession Adjusted EBITDAC Margins
    around 35%
    medium materiality
    High
    Contingent Commissions (Company-wide)
    up this year
    high materiality
    High
    Overall Organic Growth Rate
    upper bound of 2.5%
    high materiality
    Medium
    EBITDA Synergies from Accession
    $30 million to $40 million
    high materiality
    High

    Segment performance

    2
    SegmentRevenueYoYQoQMargin
    Retail
    Growth driven primarily by acquisition activity. Organic growth impacted by a pharmacy consulting business revenue model change and lower net new business. EBITDAC margin decrease due to quarterly weighting of revenue and profit for legacy Brown & Brown vs. Risk Strategies, offset by underlying margin expansion and a net benefit from departed individuals.
    Organic growth (incl. contingents): 1.3%Organic growth (excl. contingents): 1%EBITDAC margin change: -130 bps
    $1.4 billion33.4%36%
    Specialty Distribution
    Growth driven by Accession acquisition and substantial increase in contingent commissions. Organic growth negatively impacted by $12 million of prior year flood claims processing revenue. Strong results despite CAT property rates declining 15-35%. EBITDAC margin increased due to higher contingents and expense management, partially offset by lower prior year flood claims processing revenue profit.
    Organic growth (incl. contingents): 3.9%Organic growth (excl. contingents): -2%Contingent commissions: $52 millionContingent commissions from Accession: $22 millionContingent commissions from favorable underwriting: $30 millionEBITDAC margin change: +30 bps
    $500 million40%40.8%

    Operational metrics

    25
    Adjusted Income before income taxes growth
    28.7%YoY
    Q1 FY26

    Growth in adjusted income before income taxes.

    Adjusted EBITDAC growth
    36.6%YoY
    Q1 FY26

    Growth in adjusted EBITDAC.

    Adjusted EBITDAC margin
    38.5%40 bps increase
    Q1 FY26

    Consolidated adjusted EBITDAC margin, showing an increase over the prior year.

    Adjusted Diluted Net Income Per Share
    $1.397.8% increase
    Q1 FY26

    Adjusted diluted net income per share for the quarter.

    Cash Flow from Operations to Total Revenues Ratio
    14%down slightly from 15%
    Q1 FY26

    Ratio declined due to Accession integration costs and higher earn-out payments.

    Effective Tax Rate
    22.8%slight increase over 21.8%
    Q1 FY26

    Increase driven by higher state taxes.

    Weighted Average Shares
    337Mincreased by approximately $52 million
    Q1 FY26

    Increase primarily due to shares issued for Accession acquisition.

    Contingent Commissions Growth
    $54M
    Q1 FY26

    Impressive growth in contingent commissions, with a portion from the Accession acquisition.

    Accession Total Revenues
    $445M
    Q1 FY26

    Total revenues recognized for the Accession business in the quarter.

    Retail EBITDAC Margin Impact from Accession
    -300 bps
    Q1 FY26

    Negative impact on Retail EBITDAC margins due to the quarterly weighting of revenue and profit for legacy Brown & Brown compared to Risk Strategies.

    Retail EBITDAC Margin Benefit from Departures
    40 to 60 bps
    Q1 FY26

    Net benefit to Retail margins from individuals who departed to the start-up, expected to moderate as new teammates are hired.

    Organic Revenue Growth (excl. contingents)
    Flatvs prior year
    Q1 FY26

    Organic revenue growth excluding contingent commissions.

    Organic Revenue Growth (incl. contingents)
    2.2%
    Q1 FY26

    Organic revenue growth including contingent commissions, presented as a comparable measure.

    Medical Costs Increase
    8% to 10%
    Q1 FY26

    Increase in medical costs for Employee Benefits.

    Pharmacy Costs Increase
    over 10%
    Q1 FY26

    Increase in pharmacy costs for Employee Benefits.

    Admitted P&C Market Rates
    Flat to up 5%vs prior year
    Q1 FY26

    General rate changes in the admitted P&C markets.

    Workers' Comp Rates
    Flat to down 3%
    Q1 FY26

    Rate changes for workers' compensation, with some modest increases in a few states.

    Non-CAT Property Rates
    Down 5% to up 5%
    Q1 FY26

    Rate changes for non-CAT property insurance.

    Casualty Lines Rates (Primary Layers)
    Increased 2% to 5%
    Q1 FY26

    Rate increases for primary layers in casualty lines, with excess layers increasing materially more.

    Professional Liability Rates
    Down 5% to up 5%
    Q1 FY26

    Rate changes for professional liability, similar to prior quarters.

    E&S Property Rates (Wind and Quake)
    Down 15% to 35%modestly more than Q4 FY25
    Q1 FY26

    Rate declines for E&S property, with customers capturing most savings or utilizing them for deductibles/limits.

    Florida Coastal Property Rate
    below $0.20
    Q1 FY26

    Example of current coastal property rates in Southeast Florida, with $0.07-$0.08 of that being the fire rate.

    Fire Rate Component (Florida Coastal Property)
    $0.07 to $0.08
    Q1 FY26

    The portion of the Florida coastal property rate attributed to fire risk.

    Hours Saved Annually by Proprietary Platform
    50,000
    Annual

    Savings from a proprietary platform that automates billing data extraction and validation.

    Retail Revenues from Accounts under $25k Premium
    1% to 2%
    Q1 FY26

    Percentage of total retail revenues generated from commercial and employee benefits accounts with premiums under $25,000 and monoline personal lines.

    Industry KPIs

    4
    MetricValueDetails
    Capital returns$350MUSD
    Catastrophe losses
    Renewal rate change pricingFlat to up 5%%
    Broker specific when present2.2%%

    Product announcements

    3
    ProductTypeDetails
    AI Agents for Submission Processlaunch
    AI Policy Checking Agentslaunch
    Proprietary Billing Data Platformlaunch

    Deals & partnerships

    1
    AccessionIntegration of Accession into Brown & Brown's operations, particularly impacting the Specialty Distribution segment.

    The acquisition of Accession is a key driver of total revenue growth and is undergoing integration efforts, including a new sales model in Retail and contributing to Specialty Distribution's performance.

    Risks & headwinds

    6
    Flood Claims Processing Revenue ImpactQ1 FY26

    Negative 100 bps impact on consolidated organic growth (ex-contingents); Negative 300 bps impact on Specialty Distribution organic growth (ex-contingents).

    Mitigation: Diversified business model and focus on other growth areas.

    Pharmacy Consulting Business Revenue Model ChangeNext couple of quarters (Q2 FY26, Q3 FY26)

    Expected negative impact of 50 to 100 basis points on Retail organic growth.

    Mitigation: Expectation for the business to start growing towards the end of the year after the transition.

    Litigation with Start-up BrokerOngoing

    $10 million impact on Q1 FY26 organic revenue growth; $31 million of annualized lost revenue (up from $23 million last quarter).

    Mitigation: Expansive Temporary Restraining Order (TRO) in Massachusetts with tight restrictions, which is still in place.

    Declining CAT Property RatesQ1 FY26 and expected to continue in Q2 FY26

    E&S property rates declined 15% to 35% in Q1 FY26, with further declines later in the quarter.

    Mitigation: Customers utilizing savings to decrease deductibles, increase limits, or buy other lines of coverage; company remains disciplined in underwriting.

    Geopolitical Turmoil and Inflationary PressuresOngoing

    Cost of oil and gas influencing some customers to adopt a more cautious outlook and balance cost increases.

    Mitigation: Customers are resilient, creative, and adaptive, expected to navigate challenges and capture growth opportunities.

    Inability to Get Higher Limits in CasualtyOngoing, not expected to change materially over coming quarters

    Extremely challenging to get higher limits; primary layers becoming more expensive, and carriers decreasing limits offered.

    Mitigation: Not explicitly stated, but implies continued focus on advisory and risk management solutions.

    What to watch in Q2 FY26

    5

    Retail Organic Growth Improvement

    Q2 FY26
    Current1% (excl. contingents) in Q1 FY26
    TargetModest sequential improvement

    Why it matters

    Indicates the effectiveness of the new sales model and the impact of the pharmacy consulting business transition.

    Based on the rate environment, the changes in one of our pharmacy consulting businesses and the operating model enhancements, we're projecting modest organic growth improvement each quarter this year as compared to the first quarter.

    Q&A highlights

    6

    How does the new blended sales model (combining legacy Brown & Brown and Risk Strategies) operate, how does it affect producer incentives, and is it moving towards competitors' models?

    The new model blends the best of both legacy regional and local sales models, creating a unique approach with industry and coverage specialization. It's designed to give producers access to more capabilities and has been positively received, not necessarily mirroring larger competitors.

    I think it's kind of unique onto ourselves. And I think it's actually been very positively received by our producers.

    asked by Robert Cox · answered by J. Powell Brown

    2 min read6 chapters

    Detailed Narrative

    01

    Market Conditions and Pricing Trends

    Economic conditions remained stable in Q1 FY26, with customer hiring and investment consistent with prior periods. Commercial insurance rates were relatively stable, except for CAT property which saw further declines. Employee Benefits pricing was similar to prior quarters, with medical costs up 8-10% and pharmacy costs up over 10%. Admitted P&C markets saw rates flat to up 5%, while E&S property rates declined 15-35%. Casualty lines continued to see price increases of 2-5% for primary layers, with higher increases for excess layers, and professional liability rates were flat to down 5%.

    02

    Technology and AI Strategy

    Brown & Brown's technology and data journey began over 10 years ago with platform rationalization and data standardization, foundational for effective AI. The company views AI as an enabler and accelerator of its existing strategy, focusing on targeted use cases with measurable success metrics. Investments are made in world-class data and AI teammates, enterprise-grade technologies, and a strong ecosystem of technology partners, combining out-of-the-box AI tools with proprietary products.

    03

    AI-Powered Solutions and Impact

    The company has several AI-powered solutions live and delivering value. AI agents automate over 25% of the end-to-end submission process for programs and wholesale businesses, leading to material cost reductions and increased underwriting capacity. In retail, policy checking agents automate manual proposal comparisons and policy reviews, improving risk insight and reducing E&O exposure. A proprietary platform electronically interfaces with carrier billing portals, saving over 50,000 hours annually by automating billing data extraction and validation.

    04

    AI and Market Disruption

    Brown & Brown believes its business segments with the highest theoretical AI exposure are admitted aggregators and highly standardized small accounts, areas where the company has not invested significant capital. The specialty distribution model, built on niche specialization, is seen as resilient due to structural moats like regulation, capital intensity, underwriting complexity, and strong carrier relationships. The company emphasizes that AI disintermediates 'how' but not 'trust,' which remains central to its advisory business model.

    05

    Accession Integration Progress

    The integration of Accession is on track, with a focus on bringing teams together, enhancing collaboration, and leveraging combined capabilities. The company expects to deliver $30 million to $40 million in EBITDA synergies from the integration this year. The combined sales model in Retail, blending regional and local approaches with industry and coverage specialization, is showing increased activity and optimism for the second half of the year.

    06

    Small Account Strategy

    The company defines small accounts as those paying under $25,000 in premium, which represent only 1% to 2% of total retail revenues. These accounts are often complex and customized, requiring specialized solutions. While some independent agents target smaller, highly standardized accounts, Brown & Brown's producers typically focus on accounts exceeding this threshold, emphasizing complex commercial risks and advisory relationships.

    AI-generated summary of the company’s earnings call. Not investment advice.